Statin use in older people--negative

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
946
Statin use in older people --negative help?

https://medium.com/@drrosswalker/statin-use-i...a000be0634

Over the past decade there have been increasing concerns raised by some people in the medical field and many members of the public about the increasing prescriptions written for statin drugs (e.g. Crestor, Lipitor, Zocor & Pravachol, along with the numerous generics) and the potential over-reporting of side-effects by the public but equally the under-reporting of side-effects in the numerous clinical trials of these drugs. Most people practising medicine would support the use of statins for people who have existing heart disease but the real question is, does it benefit people purely because the cholesterol is elevated without evidence of any vascular problems?
A recent study published in JAMA-Internal Medicine journal has raised concerns about the use of statins for people without heart disease, over the age of 65. Statins are the major group of drugs used to block the production of cholesterol in the liver and have been shown in a number of trials in people with existing heart disease to reduce further cardiac events.

There is, however, no data to support the use of statins for people over the age of 75. Despite this, the use of statins in people 79 years or older has increased threefold from the 1990s until most recently. This has increased from 9% to 34% over the last decade.The researchers analysed data from a long-standing trial called ALLHAT-LLT otherwise known as the “Antihypertensive and lipid-lowering treatments to prevent heart attack trial-lipid lowering trial”. This was a placebo, controlled trial of just under 2,900 people without heart disease, where half were given Pravachol 40 mg daily and the other half usual care. Pravachol is the weakest of the 4 commonly prescribed statins. In people over the age of 65 up to age 74 there were more deaths in the statin group than the usual care group (141 versus 113). This was also the case in people older than 75 (92 deaths versus 65 deaths respectively). The rates of overall cardiovascular events were slightly lower in the statin group versus the usual care group(76 versus 89) and for those 75 or older (31 versus 39). The conclusion of the trial was that there were no benefits using statins for primary prevention in people over the age of 65. An editorial by the editor of Harvard Health publications suggested that the musculoskeletal abnormalities and potential memory problems from statin use in older people could further compromise a person’s ability to function in daily life.The conclusion of the trial was “the combination of these multiple risks and the ALLHAT-LLT data showing that statin therapy in older adults may be associated with an increased mortality rate should be considered before prescribing or continuing statins for patients in this age category.” For many years, a minority of doctors, including my colleague and friend Dr Aseem Malhotra, and I have been warning about the excessive use of statins by the medical profession. A few years back, Dr Maryanne Demasi was vilified by the medical profession following a segment on the ABC catalyst program where she dared to suggest that statin drugs were being overprescribed. Since her public vilification, the arguments put forward by Dr Demasi have been substantiated by a number of trials including the one mentioned above and it’s now time that the medical profession re-evaluated the excessive prescription of these medications. For many years, I have only prescribed statins to people who have existing cardiovascular disease such as prior heart attack, stent or coronary bypass surgery or if they have a significant load of atherosclerosis, as seen by a coronary calcium score or on carotid ultrasound. It is time that the conservative elements of medicine admit they were wrong and only prescribe statin drugs for people with appropriate indications. The first line of the Hippocratic Oath states, “First, do no harm.”

The excessive prescription of statins is certainly an extremely good example of where the medical profession can cause more harm than good.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 1

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 2

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 2

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 3

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Havoc, CSBC Partner for Autonomous Maritime Future

Updated Category News Views 3

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Continue Reading

Top 5 Most Recently Viewed Articles

Advanced Control Solutions Partners with CaPow for Efficient Automation

Updated Category News Views 331

Advanced Control Solutions Partners with CaPow Offering boosts warehouse uptime and ROI with smart automation solutions In a significant move, Advanced Control Solutions & Automation (ACS), recognized as a leader in the Southeast U.S. for Value Add distribution of automation equipment, has formed a partnership with CaPow, the innovators behind Genesis—a cutting-edge...

Continue Reading
Understanding Mondelez International's Market Performance

Updated Category News Views 171

Analyzing Mondelez International's Stock Price Movements As of the latest trading session, Mondelez International Inc. (NASDAQ: MDLZ) is valued at $68.39, reflecting a slight decrease of 0.62%. Despite this minor drop, the stock has demonstrated a monthly increase of 1.41% and a yearly growth of 3.43%. This raises an interesting question for investors: Is the stock...

Continue Reading
Dada Nexus Limited Engages Advisors to Assess Proposal Offer

Updated Category News Views 162

Overview of Dada Nexus Limited's Recent Appointment Dada Nexus Limited (NASDAQ: DADA) is making headlines as the company recently appointed a financial advisor and legal counsel to assist its independent special committee. This committee has been tasked with scrutinizing an initial non-binding proposal submitted earlier this year. The incorporation of Kroll, LLC as the...

Continue Reading
Revolutionizing Oxygen Therapy with Innovative Device Design

Updated Category News Views 181

Enhancing Portable Oxygen Concentrators for Better Health Innovations in medical technology have always aimed at improving patient care, and the development of a new device serves as a prime example. An inventor has recently conceptualized a portable oxygen concentrator called the AUTO TITRATING OXYGEN CONCENTRATOR. This new design focuses on controlling the delivery rate...

Continue Reading
Assumption University's Innovative Healthcare Programs Shine Bright

Updated Category News Views 185

Assumption University's Innovative Healthcare Programs Assumption University is making significant strides in enhancing educational opportunities for aspiring healthcare professionals, recently earning national acclaim for its academic excellence and innovative programs. The institution's commitment to healthcare education is reflected in its new initiatives aimed at...

Continue Reading